Emerging Links between Cadmium Exposure and Insulin Resistance : Human, Animal, and Cell Study Data
Recent research has helped clarify the role of cadmium (Cd) in various pathological states. We have demonstrated Cd involvement in pancreatic cancer, as well as the bioaccumulation of Cd in the pancreas. Bioaccumulation and increased toxicity suggest that Cd may also be involved in other pancreas-mediated diseases, like diabetes. Cd falls into the category of "hyperglycemic" metals, i.e., metals that increase blood glucose levels, which could be due to increased gluconeogenesis, damage to β-cells leading to reduced insulin production, or insulin resistance at target tissue resulting in a lack of glucose uptake. This review addresses the current evidence for the role of Cd, leading to insulin resistance from human, animal, and in vitro studies. Available data have shown that Cd may affect normal insulin function through multiple pathways. There is evidence that Cd exposure results in the perturbation of the enzymes and modulatory proteins involved in insulin signal transduction at the target tissue and mutations of the insulin receptor. Cd, through well-described mechanisms of oxidative stress, inflammation, and mitochondrial damage, may also alter insulin production in β-cells. More work is necessary to elucidate the mechanisms associated with Cd-mediated insulin resistance.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2020 |
---|---|
Erschienen: |
2020 |
Enthalten in: |
Zur Gesamtaufnahme - volume:8 |
---|---|
Enthalten in: |
Toxics - 8(2020), 3 vom: 27. Aug. |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Buha, Aleksandra [VerfasserIn] |
---|
Links: |
---|
Themen: |
β-cell toxicity |
---|
Anmerkungen: |
Date Revised 29.03.2024 published: Electronic Citation Status PubMed-not-MEDLINE |
---|
doi: |
10.3390/toxics8030063 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM314401318 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM314401318 | ||
003 | DE-627 | ||
005 | 20240329234719.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2020 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.3390/toxics8030063 |2 doi | |
028 | 5 | 2 | |a pubmed24n1354.xml |
035 | |a (DE-627)NLM314401318 | ||
035 | |a (NLM)32867022 | ||
035 | |a (PII)E63 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Buha, Aleksandra |e verfasserin |4 aut | |
245 | 1 | 0 | |a Emerging Links between Cadmium Exposure and Insulin Resistance |b Human, Animal, and Cell Study Data |
264 | 1 | |c 2020 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Revised 29.03.2024 | ||
500 | |a published: Electronic | ||
500 | |a Citation Status PubMed-not-MEDLINE | ||
520 | |a Recent research has helped clarify the role of cadmium (Cd) in various pathological states. We have demonstrated Cd involvement in pancreatic cancer, as well as the bioaccumulation of Cd in the pancreas. Bioaccumulation and increased toxicity suggest that Cd may also be involved in other pancreas-mediated diseases, like diabetes. Cd falls into the category of "hyperglycemic" metals, i.e., metals that increase blood glucose levels, which could be due to increased gluconeogenesis, damage to β-cells leading to reduced insulin production, or insulin resistance at target tissue resulting in a lack of glucose uptake. This review addresses the current evidence for the role of Cd, leading to insulin resistance from human, animal, and in vitro studies. Available data have shown that Cd may affect normal insulin function through multiple pathways. There is evidence that Cd exposure results in the perturbation of the enzymes and modulatory proteins involved in insulin signal transduction at the target tissue and mutations of the insulin receptor. Cd, through well-described mechanisms of oxidative stress, inflammation, and mitochondrial damage, may also alter insulin production in β-cells. More work is necessary to elucidate the mechanisms associated with Cd-mediated insulin resistance | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Review | |
650 | 4 | |a cadmium | |
650 | 4 | |a diabetes | |
650 | 4 | |a hyperglycemia | |
650 | 4 | |a hyperinsulinemia | |
650 | 4 | |a insulin | |
650 | 4 | |a lipogenic | |
650 | 4 | |a β-cell toxicity | |
700 | 1 | |a Đukić-Ćosić, Danijela |e verfasserin |4 aut | |
700 | 1 | |a Ćurčić, Marijana |e verfasserin |4 aut | |
700 | 1 | |a Bulat, Zorica |e verfasserin |4 aut | |
700 | 1 | |a Antonijević, Biljana |e verfasserin |4 aut | |
700 | 1 | |a Moulis, Jean-Marc |e verfasserin |4 aut | |
700 | 1 | |a Goumenou, Marina |e verfasserin |4 aut | |
700 | 1 | |a Wallace, David |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Toxics |d 2014 |g 8(2020), 3 vom: 27. Aug. |w (DE-627)NLM242207073 |x 2305-6304 |7 nnns |
773 | 1 | 8 | |g volume:8 |g year:2020 |g number:3 |g day:27 |g month:08 |
856 | 4 | 0 | |u http://dx.doi.org/10.3390/toxics8030063 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 8 |j 2020 |e 3 |b 27 |c 08 |